As of 2024-12-15, the Relative Valuation of Shield Therapeutics PLC (STX.L) is (54.57) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 2.75 GBP, the upside of Shield Therapeutics PLC based on Relative Valuation is -2084.3%.
The range of the Relative Valuation is (56.14) - (66.50) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 15.8x | 13.5x |
| Forward P/E multiples | 9.9x - 14.4x | 10.1x |
| Fair Price | (56.14) - (66.50) | (54.57) |
| Upside | -2141.5% - -2518.2% | -2084.3% |
| Date | P/E |
| 2024-12-12 | -0.60 |
| 2024-12-11 | -0.59 |
| 2024-12-10 | -0.61 |
| 2024-12-09 | -0.62 |
| 2024-12-06 | -0.64 |
| 2024-12-05 | -0.62 |
| 2024-12-04 | -0.62 |
| 2024-12-03 | -0.62 |
| 2024-12-02 | -0.62 |
| 2024-11-29 | -0.63 |
| 2024-11-28 | -0.62 |
| 2024-11-27 | -0.62 |
| 2024-11-26 | -0.63 |
| 2024-11-25 | -0.62 |
| 2024-11-22 | -0.62 |
| 2024-11-21 | -0.64 |
| 2024-11-20 | -0.58 |
| 2024-11-19 | -0.63 |
| 2024-11-18 | -0.57 |
| 2024-11-15 | -0.58 |
| 2024-11-14 | -0.58 |
| 2024-11-13 | -0.57 |
| 2024-11-12 | -0.57 |
| 2024-11-11 | -0.58 |
| 2024-11-08 | -0.59 |
| 2024-11-07 | -0.59 |
| 2024-11-06 | -0.59 |
| 2024-11-05 | -0.59 |
| 2024-11-04 | -0.61 |
| 2024-11-01 | -0.65 |
| 2024-10-31 | -0.65 |
| 2024-10-30 | -0.63 |
| 2024-10-29 | -0.75 |
| 2024-10-28 | -0.82 |
| 2024-10-25 | -0.86 |
| 2024-10-24 | -0.88 |
| 2024-10-23 | -0.88 |
| 2024-10-22 | -0.99 |
| 2024-10-21 | -0.99 |
| 2024-10-18 | -0.98 |
| 2024-10-17 | -0.99 |
| 2024-10-16 | -0.98 |
| 2024-10-15 | -1.02 |
| 2024-10-14 | -1.06 |
| 2024-10-11 | -1.02 |
| 2024-10-10 | -0.93 |
| 2024-10-09 | -0.89 |
| 2024-10-08 | -0.90 |
| 2024-10-07 | -0.89 |
| 2024-10-04 | -0.91 |